The Role of Halogen Bonding in Inhibitor Recognition and Binding by Protein Kinases

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-07 ,pp. : 1336-1348

Bentham Science Publishers

Access to resources Recommend Favorite

The Design of Drug Candidate Molecules as Selective Inhibitors of Therapeutically Relevant Protein Kinases

By  

Current Medicinal Chemistry, Vol. 11, Iss. 12, 2004-06 ,pp. : 1563-1583

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase Inhibition: Different Approaches to Selective Inhibitor Design

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1443-1454

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition

By Backes AC   Zech B   Felber B   Klebl B   Müller G  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1409-1425

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of cytosolic phospholipase A 2 attenuates activation of mitogen-activated protein kinases in human monocytic cells

By Burgermeister E.   Pessara U.   Tibes U.   Kuster A.   Heinrich P.C.   Scheuer W.V.  

European Journal of Pharmacology, Vol. 388, Iss. 3, 2000-02 ,pp. : 195-208

Elsevier

Access to resources Recommend Favorite